{
    "clinical_study": {
        "@rank": "156297", 
        "arm_group": [
            {
                "arm_group_label": "Same day PEG", 
                "arm_group_type": "Active Comparator", 
                "description": "group 1 (same day PEG, N=50) received 4 L of PEG at 6 hours before procedure on the day of the colonoscopy"
            }, 
            {
                "arm_group_label": "split PEG", 
                "arm_group_type": "Active Comparator", 
                "description": "group 2 (split PEG, N=50) received 2 L of PEG at 6:00 p.m the evening before colonoscopy and 2 L of PEG at 4-6 hours before procedure"
            }, 
            {
                "arm_group_label": "SPMC 2", 
                "arm_group_type": "Active Comparator", 
                "description": "group 3 (SPMC 2, N=50) received one sachet of SPMC at 6 p.m the evening before colonoscopy and another sachet of SPMC at 4-6 hours before procedure"
            }, 
            {
                "arm_group_label": "SPMC 3", 
                "arm_group_type": "Active Comparator", 
                "description": "group 4 (SPMC 3, N=50) received one sachet of SPMC at 6 p.m and the other sachet at 9 p.m the evening before colonoscopy and another sachet at 4-6 hours before procedure."
            }
        ], 
        "brief_summary": {
            "textblock": "Adequate bowel cleansing is important for a completeness of colonoscopy and detection of\n      colon polyps. Inadequate bowel preparation leads to longer duration of colonoscopy and\n      obscured mucosal visualization resulting in missed lesions.\n\n      Bowel cleansing agents are simply classified into the large volume, iso-osmotic polyethylene\n      glycol (PEG) based solutions or the small volume osmotically active agents, such as sodium\n      picosulphate with magnesium citrate (SPMC).\n\n      There are rare reports that compare directly conventional polyethylene glycol (PEG) solution\n      and sodium picosulphate with magnesium citrate (SPMC) for bowel preparation in korea.\n\n      The aim of this study is to compare the efficacy, safety, and tolerability of different\n      regimens of SPMC and PEG solution."
        }, 
        "brief_title": "A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Colorectal Cancer", 
            "Colon Adenoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenoma", 
                "Colorectal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. Study design: endoscopist-blinded, prospective, randomized controlled trial\n\n        2. Subjects\n\n             1. Entry criteria: Male or female patients, aged between18 and 75 years undergoing\n                elective outpatient colonoscopy were eligible for the study.\n\n             2. Exclusion criteria:\n\n           gastrointestinal obstruction or perforation, toxic megacolon, severe uncontrolled\n           inflammatory bowel disease, previous colorectal resection, congestive heart failure,\n           recent acute myocardial infarction or unstable angina, uncontrolled arterial\n           hypertension, renal insufficiency with glomerular filtration rate < 60 ml/minute/1.73\n           m2, liver cirrhosis or ascites, pregnancy, lactation, and history of hypersensitivity\n           to any bowel cleansing agents.\n\n        3. Sampling design: Consecutive recruitment of consenting patients\n\n        4. Variables Predictor\n\n             1. group 1 (same day PEG) received 4 L of PEG at 6 hours before procedure on the day\n                of the colonoscopy\n\n             2. group 2 (split PEG) received 2 L of PEG at 6:00 p.m the evening before colonoscopy\n                and 2 L of PEG at 4-6 hours before procedure\n\n             3. group 3 (SPMC 2) received one sachet of SPMC at 6 p.m the evening before\n                colonoscopy and another sachet of SPMC at 4-6 hours before procedure;\n\n             4. group 4 (SPMC 3) received one sachet of SPMC at 6 p.m and the other sachet at 9\n                p.m the evening before colonoscopy and another sachet at 4-6 hours before\n                procedure.\n\n        5. Primary Outcome: Quality of bowel preparation (Ottawa scale)\n\n        6. Secondary Outcome: Tolerability, palatability, side effect of the cleansing agents"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female patients, aged between18 and 75 years undergoing elective outpatient\n             colonoscopy were eligible for the study\n\n        Exclusion Criteria:\n\n          -  gastrointestinal obstruction or perforation, toxic megacolon, severe uncontrolled\n             inflammatory bowel disease, previous colorectal resection, congestive heart failure,\n             recent acute myocardial infarction or unstable angina, uncontrolled arterial\n             hypertension, renal insufficiency with glomerular filtration rate < 60 ml/minute/1.73\n             m2, liver cirrhosis or ascites, pregnancy, lactation, and history of hypersensitivity\n             to any bowel cleansing agents."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01778192", 
            "org_study_id": "Korea University"
        }, 
        "intervention": [
            {
                "arm_group_label": "Same day PEG", 
                "description": "-group 1 (same day PEG) received 4 L of PEG at 6 hours before procedure on the day of the colonoscopy", 
                "intervention_name": "Polyethylene glycol", 
                "intervention_type": "Drug", 
                "other_name": "Colyte(Taejoon Pharmaceuticals, Seoul, Korea)"
            }, 
            {
                "arm_group_label": "split PEG", 
                "description": "-group 2 (split PEG, N=50) received 2 L of PEG at 6:00 p.m the evening before colonoscopy and 2 L of PEG at 4-6 hours before procedure", 
                "intervention_name": "Polyethylene glycol", 
                "intervention_type": "Drug", 
                "other_name": "Colyte(Taejoon Pharmaceuticals, Seoul, Korea)"
            }, 
            {
                "arm_group_label": "SPMC 2", 
                "description": "-group 3 (SPMC 2) received one sachet of SPMC at 6 p.m the evening before colonoscopy and another sachet of SPMC at 4-6 hours before procedure", 
                "intervention_name": "Sodium picosulphate with magnesium citrate", 
                "intervention_type": "Drug", 
                "other_name": "Picolight(Pharmbio korea, Seoul, Korea)"
            }, 
            {
                "arm_group_label": "SPMC 3", 
                "description": "-group 4 (SPMC 3) received one sachet of SPMC at 6 p.m and the other sachet at 9 p.m the evening before colonoscopy and another sachet at 4-6 hours before procedure.", 
                "intervention_name": "Sodium picosulphate with magnesium citrate", 
                "intervention_type": "Drug", 
                "other_name": "Picolight(Pharmbio korea, Seoul, Korea)"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Picosulfate sodium", 
                "Magnesium citrate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bowel preparation", 
            "Polyethylene glycol", 
            "Sodium picosulphate"
        ], 
        "lastchanged_date": "January 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "ASI/KR/KS013/SEOUL"
                }, 
                "name": "Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized Prospective Trial Comparing Different Regimens of Polyethylene Glycol-based Lavage and Sodium Picosulphate With Magnesium Citrate in the Preparation of Patients for Colonoscopy", 
        "overall_official": [
            {
                "affiliation": "Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea", 
                "last_name": "Yoon Tae Jeen", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea", 
                "last_name": "Eun Sun Kim", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea", 
                "last_name": "Woo Jin Lee", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Immediately following the colonoscopy, the endoscopist who were unaware of the preparation regimen scored the quality of the bowel preparation using the Ottawa bowel preparation scale (OBPS).", 
            "measure": "the quality of the bowel preparation using the Ottawa bowel preparation scale (OBPS)", 
            "safety_issue": "No", 
            "time_frame": "20 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01778192"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University Anam Hospital", 
            "investigator_full_name": "Woo-Jin Lee", 
            "investigator_title": "fellow", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Patient compliance was recorded by checking the completeness of the prescribed preparation methods including bowel cleansing agent solution and recommended clear liquid.", 
                "measure": "Completeness of the bowel preparation", 
                "safety_issue": "No", 
                "time_frame": "30 minutes before the colonoscopy"
            }, 
            {
                "description": "Patients were asked with questionnaires about the symptoms associated with the preparation to assess the patients' tolerability before the colonoscopy. Patients were asked whether they experienced any of the following : abdominal fullness, cramping, nausea, vomiting, sleep disturbance, and overall discomfort, and these symptoms were scored on a 5-point scale where 1 = \"none\", 2 = \"mild\", 3 = \"moderate\", 4 = \"severe\", and 5 = \"very severe\".", 
                "measure": "the patient's tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes before the colonoscopy"
            }, 
            {
                "description": "Biochemical measures detected outrange of serum electrolytes (sodium, potassium, chloride, calcium, magnesium, and phosphate), blood urea nitrogen, creatinine and serum osmolality only for the sodium picosulphate and magnesium citrate.\nBiochemical measurement was done done for the patients in the polyethylene glycol groups due to the well established safety date of the polyethylene glycol solutions.", 
                "measure": "the side effects of the sodium picosulphate and magnesium citrate", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour before the colonoscopy"
            }
        ], 
        "source": "Korea University Anam Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Korea University Anam Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}